Cargando…
Pharmacokinetics, absorption, distribution, metabolism and excretion of the MEK inhibitor zapnometinib in rats
Zapnometinib is a MEK inhibitor currently under clinical development for the treatment of COVID-19 and influenza. Zapnometinib has both antiviral and immunomodulatory effects. Information concerning the absorption, distribution, metabolism, and excretion of the compound following single oral doses o...
Autores principales: | Füll, Yvonne, Wallasch, Christian, Hilton, Ashley, Planz, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760738/ https://www.ncbi.nlm.nih.gov/pubmed/36545320 http://dx.doi.org/10.3389/fphar.2022.1050193 |
Ejemplares similares
-
Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans
por: Koch-Heier, Julia, et al.
Publicado: (2022) -
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs
por: Schreiber, André, et al.
Publicado: (2022) -
Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Naringin in Aged Rats
por: Zeng, Xuan, et al.
Publicado: (2019) -
Pharmacokinetics, Tissue Distribution, and Excretion Characteristics of a Radix Polygoni Multiflori Extract in Rats
por: Cheng, Wenhao, et al.
Publicado: (2022) -
Preclinical Absorption, Distribution, Metabolism, and Excretion of Sodium Danshensu, One of the Main Water-Soluble Ingredients in Salvia miltiorrhiza, in Rats
por: Meng, Xiangguo, et al.
Publicado: (2019)